Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?

To date, the PRO development process has consistently lacked clear definitions of concepts of interest, use of conceptual frameworks and patient involvement, thereby compromising the validity of data they generate. PRO instrument development must be conducted more robustly to maximise the value of pivotal clinical trials.